$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
Omicron-Specific Booster Shots May Not Be Needed, Fauci Says
01:20pm, Friday, 10'th Dec 2021 Barron''s
The comment by Biden''s top medical advisor seems to match the view of Pfizer and BioNTech that three doses of the original vaccine might offer protection.
Billionaire BioNTech backers have been kicking the tires at Novartis'' big generics arm report
12:14pm, Friday, 10'th Dec 2021 Endpoints News
While the ultimate fate of Novartis big generics arm Sandoz may still be up in the air, theres no doubt its in play as a potential buyout target. Overnight, Reuters picked up on a report out of Germany that EQT and the billionaire Strüngmann brothers enjoying a huge windfall
Why BioNTech Stock Is Sinking Today
11:53am, Friday, 10'th Dec 2021
Good news from the FDA wasn't enough to outweigh less positive updates this week.
Pfizer-BioNTech COVID-19 Booster Gets FDA Approval for Ages 16 & Older
10:57am, Friday, 10'th Dec 2021 Smarter Analyst
This article was originally published on TipRanks.com The booster dose of the Pfizer (PFE) BioNTech (BNTX) COVID-19 vaccine has received extended authorization for The post Pfizer-BioNTech COVID-19 Booster Gets FDA Approval for Ages 16 & Older appeared first on Smarter Analyst .
Pfizer, BioNTech Booster Gets FDA Nod for 16- & 17-Year Olds
09:59am, Friday, 10'th Dec 2021
FDA authorizes the booster shot of Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine for 16- and 17-year olds.
US expands Pfizer COVID boosters for children
07:01am, Friday, 10'th Dec 2021 Jamaica Observer
WASHINGTON, United States (AP) - United States health authorities said yesterday that 16 and 17 year olds should get a booster dose of Pfizer''s COVID-19 vaccine once they''re six months past their last shot. The US and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new Omicron variant. Yesterday, the Food and Drug Administration (FDA) gave emergency authorisation for 16 and 17 year olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech. And hours later, the Centers for Disease Control and Prevention (CDC) lifted the last barrier - saying those teens should get their booster as soon as it''s time. Boosters are important considering that protection against infection wanes over time and "we''re facing a variant that has the potential to require more immunity to be protected," Dr Rochelle Walensky, CDC''s director, told The Associated Press.
Pfizer CEO says fourth dose of vaccine may be needed for omicron
04:14am, Friday, 10'th Dec 2021 Conservative Institute
After Pfizer BioNTech released initial findings about its vaccines perceived protection against COVID-19, CEO Albert Bourla said Wednesday that a fourth shot may eventually be needed to combat the new omicron variant. Pfizer, the CDC and the Biden administration are encouraging those who received two doses of any mRNA vaccine or one dose of the [] The post Pfizer CEO says fourth dose of vaccine may be needed for omicron first appeared on Conservative Institute .
Pfizer Says 3 Doses of Its Covid-19 Vaccine Neutralizes Omicron Variant
02:02am, Friday, 10'th Dec 2021 Antigua News Room
Pfizer and BioNTech said three doses of their Covid-19 vaccine neutralize the Omicron coronavirus variant, according to the results of an initial laboratory study. The data showed a third dose of the vaccine increases neutralizing antibodies by 25-fold compared with two doses, strengthening the case for and need for booster shots. The preliminary data suggest three doses provide [] The post Pfizer Says 3 Doses of Its Covid-19 Vaccine Neutralizes Omicron Variant appeared first on Antigua News Room .
US FDA authorises Pfizer, BioNTech booster for kids aged 16 and 17
12:02am, Friday, 10'th Dec 2021 Geo TV Pakistan
All US adults are currently eligible for booster shots of the three authorised COVID-19 vaccines
Omicron variant is more transmissible than delta, according to study from Japan
08:00pm, Thursday, 09'th Dec 2021 Deseret
COVID-19 testing is performed for two individuals at the Mount Olympus Senior Center parking lot in Millcreek on Tuesday, Oct. 5, 2021. A new study in Japan found that the omicron variant of the coronavirus is 4.2 times more contagious in its early stages than the delta variant, per Barron’s. | Jeffrey D. Allred, Deseret News A study in Japan found that the omicron variant is 4.2 times more contagious in the early stages than the delta variant A new study in Japan found that the omicron variant of the coronavirus is 4.2 times more contagious in its early stages than the delta variant, per Barron’s . “The Omicron variant transmits more, and escapes immunity built naturally and through vaccines more,” said Hiroshi Nishiura, professor of health and environmental sciences at Kyoto University who conducted the study, the report added. The study used genome data from the Gauteng province in South Africa. Currently, the study hasn’t been peer-reviews or published in a scientific journal. On Wednesday, World Health Organization officials said that preliminary data points to high transmission rates with minor cases, still rapidly spreading across the globe, according to Economic Times .
Biontech co-founders: Three doses of BioNTech vaccine protect against Omicron variant
05:26pm, Thursday, 09'th Dec 2021 Business Turkey Today
Ugur Sahin and Özlem Türeci, co-founders of BioNTech, who made important statements about the Omicron mutation of Kovid-19 (also called The post Biontech co-founders: Three doses of BioNTech vaccine protect against Omicron variant appeared first on Doing Business in Turkey .
Pfizer Inc.: Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
05:10pm, Thursday, 09'th Dec 2021 FinanzNachrichten
First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
05:07pm, Thursday, 09'th Dec 2021 Business Wire
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. The booster dose is to be administered at least six months after completion of the primary series and is the same formulation and dosage strength as the doses in the primary se
Fauci: Definition Of ''Fully Vaccinated'' Will Be Changed
05:00pm, Thursday, 09'th Dec 2021 Zero Hedge
Fauci: Definition Of ''Fully Vaccinated'' Will Be Changed Authored by Zachary Stieber via The Epoch Times, The definition of fully vaccinated in the United States will be changed, Dr. Anthony Fauci said Wednesday. “It’s going to be a matter of when, not if,” Fauci, the head of the National Institute of Allergy and Infectious Diseases, said during an appearance on CNN. The term fully vaccinated presently refers to a person who receives two doses of the Pfizer or Moderna COVID-19 vaccines or the single-shot Johnson & Johnson jab. Fauci previously said the definition could be changed. Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC)—which set the definition—has left open the possibility of changing it. The definition is used by authorities imposing vaccine mandates across the country , including the federal mandates against healthcare workers and government contractors. Several of those mandates have been blocked in courts for now due to worries they’re illegal.
Sign In
Buy BNTX